Skip to main content
Equibles

Caption Management, LLC

Position in ARDX — Ardelyx, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$663,000
+$38,842 QoQ
Shares Held
130,000
+24.8% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#83
of 250 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Derivatives in ARDX

reported options exposure · as of Jun 30, 2026
CallValue
$765,000
CallShares
150,000
PutValue
$1,020,000
PutShares
200,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. ARDX ranks #49 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in ARDX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $765,000 150,000
2026-06-30 $663,000 130,000
2026-06-30 $1,020,000 200,000
2026-03-31 $624,158 104,200
2026-03-31 $1,198,000 200,000
2026-03-31 $898,500 150,000
2025-12-31 $240,196 41,200
2025-12-31 $670,450 115,000
2025-06-30 $511,560 130,500
2024-12-31 $202,800 40,000
2024-12-31 $175,422 34,600
2024-09-30 $275,600 40,000
2023-12-31 $124,000 20,000
2023-12-31 $325,500 52,500
2023-12-31 $121,520 19,600
2022-12-31 $110,580 38,800
2020-12-31 $122,930 19,000